On Jun 29, 2021 Xenothera was awarded by a €2,160,000 Grant from European Innovation Council.

About the company: Xenothera is located in Nantes, France, Europe. “The french startup Xenothera, founded in 2014, is a xenotherapy platform with embedded technology that renovates immunological treatments. Xenothera works on the therapeutic domains on Immunology, Oncology, and Infectious Diseases.  Within less than 5 years, XENOTHERA has brought to clinic its first product LIS1, a novel induction treatment in Solid Organ Transplantation, addressing a $1Bn market. It has also established in vivo Proof-of-Concept in Immuno-Oncology and Multi-Drug Resistant infections.”

Company website: www.xenothera.com/